QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=63E08D282D2D089C009FDD91A09112B1;jsessionid=6B496EC156BE815DA0003CBD89C2F760;jsessionid=19FB0235DE8556D4309B2FCFE6C94028;jsessionid=1CE388788201F56F267D9D5FF5157812 (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII.

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=63E08D282D2D089C009FDD91A09112B1;jsessionid=6B496EC156BE815DA0003CBD89C2F760;jsessionid=19FB0235DE8556D4309B2FCFE6C94028;jsessionid=1CE388788201F56F267D9D5FF5157812